Corticosteroid formulation comprising less than 2.5 mg prednisolone for once daily administration

A unit dose formulation comprises less than 2.5 mg of prednisolone or an equivalent, equipotent amount of another corticosteroid. Once daily administration of the unit dose formulation between midnight and 6 a.m. for the treatment of rheumatoid arthritis.

Saved in:
Bibliographic Details
Main Authors HAZEL JUDITH BARDSLEY, ROBIN MARK BANNISTER, JULIAN CLIVE GILBERT
Format Patent
LanguageEnglish
Published 02.04.2002
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A unit dose formulation comprises less than 2.5 mg of prednisolone or an equivalent, equipotent amount of another corticosteroid. Once daily administration of the unit dose formulation between midnight and 6 a.m. for the treatment of rheumatoid arthritis.
AbstractList A unit dose formulation comprises less than 2.5 mg of prednisolone or an equivalent, equipotent amount of another corticosteroid. Once daily administration of the unit dose formulation between midnight and 6 a.m. for the treatment of rheumatoid arthritis.
Author JULIAN CLIVE GILBERT
HAZEL JUDITH BARDSLEY
ROBIN MARK BANNISTER
Author_xml – fullname: HAZEL JUDITH BARDSLEY
– fullname: ROBIN MARK BANNISTER
– fullname: JULIAN CLIVE GILBERT
BookMark eNqFjDsOwjAQBV1Awe8M7AVAfBQRyigCcQCo0crehJXsXcs2BbcnIHqqKd68mZqRqNDEYKupsNVcKCk76DSFp8fCKmA1xMSZpQdPOUN5oMBuXUHoISZywln9UPmcQMUSOGT_AnSBh62kb2Zuxh36TIsfZ2Z5Pl3by4qi3ilHtCRU7s2tPtTHarNt9v-NN6xcPzI
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Edition 7
ExternalDocumentID AU8789501A
GroupedDBID EVB
ID FETCH-epo_espacenet_AU8789501A3
IEDL.DBID EVB
IngestDate Fri Jul 19 15:57:30 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU8789501A3
Notes Application Number: AU19870089501
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020402&DB=EPODOC&CC=AU&NR=8789501A
ParticipantIDs epo_espacenet_AU8789501A
PublicationCentury 2000
PublicationDate 20020402
PublicationDateYYYYMMDD 2002-04-02
PublicationDate_xml – month: 04
  year: 2002
  text: 20020402
  day: 02
PublicationDecade 2000
PublicationYear 2002
RelatedCompanies ARAKIS LTD
RelatedCompanies_xml – name: ARAKIS LTD
Score 2.555087
Snippet A unit dose formulation comprises less than 2.5 mg of prednisolone or an equivalent, equipotent amount of another corticosteroid. Once daily administration of...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
STEROIDS
Title Corticosteroid formulation comprising less than 2.5 mg prednisolone for once daily administration
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020402&DB=EPODOC&locale=&CC=AU&NR=8789501A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT4NAEJ7UatSbVk1978FwQ8vysofGtDzSmPQR05reGpbdKokCoRjjv3d2Az4OPUEgTNhlZr6dZb4ZgBtuccacmOpcmBigWA7XIzcSqMuRQHhgLlcs_tHYGc6tx4W9aMBrzYVRdUI_VXFEtKgY7b1U_jr_3cTyVW7l-o4leCl7CGc9X6ujY4o6STV_0AumE3_iaZ6HkaQ2fkKvft-1O0Z_C7blIlpW2Q-eB5KTkv8FlPAAdqYoKy0PoSHSFux5dd-1FuyOqt_deFpZ3voIIi-T31hSMoos4USuNavOW0SmhaOtIgiRN3RcRO6GE3prk_cXkheCpwkqWJYK-RCRNEXCcWhfJPpXOPcYrsNg5g11fNflz7Qs-_N6UOYJNFMU0wZiCcc2mNOJbdOxDMtlER44YnRMu_aKxqfQ3iTlbPOtc9hXXVBkxgq9gGZZfIhLBOOSXal5_AZd7JFk
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT4NAEJ7Uaqw3rZr67B4Mt2q75WEPjWmhBLWvGGp6Iyy7VRKFhmKM_97ZTfFx6AkCYcIu8-DbnW8G4IrrnDEzog0u2ghQdJM3QisUqMuhwPDALK5Y_KOx6c30h7kxL8FrwYVRdUI_VXFEtKgI7T1X_nr5u4jlqNzK1Q2L8VJ65_pdRyvQMUWdpJrT7w6mE2dia7aNSFIbP6FXv-0YzVZvC7YtBIQKKD33JSdl-TeguPuwM0VZSX4AJZFUoWIXfdeqsDtab3fj6dryVocQ2qn8xpKSkaUxJ_Jfc915i8i0cLRVDELkDR0XkavhhF4b5P2FLDPBkxgVLE2EfIhImiLhOLQvEv4rnHsEdXfg214D3zX4mZagNysG1T6GcoJiakB0YRotZjYjo23qLd1iIR44xuiIdowFjU6gtknK6eZbdah4_mgYDO_Hj2ewpzqiyOwVeg7lPPsQFxiYc3ap5vQbUCmUTg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Corticosteroid+formulation+comprising+less+than+2.5+mg+prednisolone+for+once+daily+administration&rft.inventor=HAZEL+JUDITH+BARDSLEY&rft.inventor=ROBIN+MARK+BANNISTER&rft.inventor=JULIAN+CLIVE+GILBERT&rft.date=2002-04-02&rft.externalDBID=A&rft.externalDocID=AU8789501A